Crestwell Healthcare Stock: SGPL Announces Rs535 Million Rights Issue
Crestwell Healthcare, formerly S.G. Power Limited, will raise up to Rs535 million through a 300% rights issue at Rs10 per share, tripling its share count if fully subscribed.
Crestwell Healthcare Limited, the company formerly listed as S.G. Power Limited, has announced a rights issue that will raise up to Rs535 million by offering existing shareholders three new shares for every one they already hold, a 300% increase in the company's share count if fully subscribed.
What the Rs535 Million Rights Issue Changed
The company will issue about 53.5 million new ordinary shares at Rs10 each, the par value, rather than at a premium. Existing shareholders as of August 19, 2026 have the right to subscribe for three new shares for every share they hold, with the subscription window running from August 24 to September 7 and payment due by September 14. Shareholders who do not want to take up their allocation can renounce their rights to another investor instead of letting them lapse. Meezan Bank has been appointed to handle the banking side of the offer.
Why Crestwell Healthcare Stock Is in Focus
Crestwell Healthcare is a company in transition. It carries the listing history of S.G. Power Limited, a power generation name, but has renamed itself around a healthcare business, and this rights issue is the clearest signal yet of how it plans to fund that shift. Raising capital through a rights issue rather than debt keeps the balance sheet free of new borrowing, but a 300% share count increase is a large dilution event for anyone who does not take up their full entitlement, since their percentage ownership and claim on future earnings shrinks accordingly.
Which Stocks, and Why
This is a company specific corporate action with no read through to any other listed name. The par value pricing at Rs10 per share, well below where rights issues are sometimes priced at a premium, suggests the company is prioritising getting the capital fully subscribed over maximising proceeds per share. What existing shareholders get in return depends entirely on what the roughly half billion rupees raised is used for, which the announcement itself does not specify beyond the mechanics of the offer.
What to Watch
The key date is September 28, 2026, when the new shares are allotted and credited to the Central Depository System, at which point the market will see the post issue share count and how much of the offer was actually taken up. Readers should also watch for any follow up disclosure on what the Rs535 million will fund, since that will determine whether this dilution translates into new earnings capacity for the healthcare business the company is now built around.
Sources
Frequently asked questions
What is Crestwell Healthcare's rights issue about?
The company, formerly S.G. Power Limited, is raising up to Rs535 million by offering three new shares for every one existing share at Rs10 per share, a 300% increase in its share count.
Will this dilute existing SGPL shareholders?
Yes, shareholders who do not subscribe to their full entitlement will see their percentage ownership reduced, since the share count can nearly quadruple if the issue is fully subscribed.
What will the Rs535 million raised be used for?
The announcement does not specify a use of proceeds beyond the mechanics of the rights issue itself.
When will the new shares be issued?
The subscription window runs from August 24 to September 7, 2026, with allotment and credit of the new shares expected on September 28, 2026.
Informational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
One story is a data point. The pattern is the edge.
Reading one story at a time, you miss how the news adds up. Track SGPL free and TradeTidings rolls every future headline into one clear positive, neutral or negative read, and alerts you the moment it turns.